Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Rabady, S; Altenberger, J; Brose, M; Denk-Linnert, DM; Fertl, E; Götzinger, F; de, la, Cruz, Gomez, Pellin, M; Hofbaur, B; Hoffmann, K; Hoffmann-Dorninger, R; Koczulla, R; Lammel, O; Lamprecht, B; Löffler-Ragg, J; Müller, CA; Poggenburg, S; Rittmannsberger, H; Sator, P; Strenger, V; Vonbank, K; Wancata, J; Weber, T; Weber, J; Weiss, G; Wendler, M; Zwick, RH.
[Guideline S1: Long COVID: Diagnostics and treatment strategies].
Wien Klin Wochenschr. 2021; 133(Suppl 7):237-278
Doi: 10.1007/s00508-021-01974-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Strenger Volker
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- This guideline comprises the state of science at the time of the editorial deadline. In view of the high turnover of knowledge the guideline is designed as a living guideline. The main objective was to provide a tool for the use in primary care, being considered well suited as a first point of entry and for the provision of care. The guideline gives recommendations on the differential diagnosis of symptoms following SARS-CoV‑2 infection, on their therapeutic options, as well as for guidance and care of the patients concerned. It also offers advice concerning return to daily life and rehabilitation. Long COVID being a very variable condition, we chose an interdisciplinary approach.
- Find related publications in this database (using NLM MeSH Indexing)
-
COVID-19 - complications
-
Humans - administration & dosage
-
SARS-CoV-2 - administration & dosage
- Find related publications in this database (Keywords)
-
Long COVID
-
Primary care
-
Diagnostik
-
Behandlung
-
Rehabilitation
-
COVID-Folgen
-
Postinfektioses Syndrom